Best HER2/neu Receptor Antagonist for breast neoplasms
Top-rated pick: Herceptin — pharmaranks score 70/100, the highest of the 2 HER2/neu Receptor Antagonist drugs used for breast neoplasms, ranked by our independent FDA recall-safety score. Compare them with all treatments for breast neoplasms or the full HER2/neu Receptor Antagonist class. Not medical advice — always consult a professional.
Quick answer: Of the 2 HER2/neu receptor antagonist drugs we rate for breast neoplasms, none are yet flagged as generics in our price data, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for breast neoplasms; the right choice depends on your situation, so confirm it with your prescriber.
Other drug classes for breast neoplasms
Top her2/neu receptor antagonist for breast neoplasms: 1. Herceptin · 2. Hercessi
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Injectable | No data | — | View → | |
| 2 | 70/100 | Prescription | Injectable | No data | — | View → |
Full ranking · 2 drugs
herceptin
Boxed warningPrescriptionFDA-sourced
Herceptin (Trastuzumab) is a HER2/neu receptor antagonist used to treat Breast Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms.
Price varies
hercessi
PrescriptionFDA-sourced
Hercessi (Trastuzumab-Strf) is a HER2/neu receptor antagonist used to treat Breast Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms.
Price varies
Frequently asked
- What is the best her2/neu receptor antagonist for breast neoplasms?
- By our independent recall-safety rating — not an efficacy measure — herceptin ranks highest among HER2/neu Receptor Antagonist drugs used for breast neoplasms. Always consult a professional.
- Which her2/neu receptor antagonist drugs treat breast neoplasms?
- pharmaranks lists 2 HER2/neu Receptor Antagonist products used for breast neoplasms, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.